Vandana Singh

Contributing Author

Recent Articles by Vandana Singh

7 hours	Tenaya Therapeutics Stock Jumps After New Alnylam Deal TNYA +40.92% ALNY Benzinga
8 hours	Veeva Systems Analyst Says AI Push Keeps Stock Attractive VEEV Benzinga
9 hours	FDA Defends Call For Placebo Study In uniQure Huntington's Gene Therapy Trial QURE +17.81% Benzinga
9 hours	Palladyne AI Forecasts Fourfold Revenue Growth In 2026 PDYN +34.05% Benzinga
10 hours	Helus Pharma Stock Tumbles As Anxiety Drug Study Disappoints HELP -33.88% ATAI VTGN Benzinga
12 hours	Medicus Pharma Stock Swings After Skin Cancer Treatment Results MDCX -50.88% Benzinga
12 hours	BioXcel Therapeutics Stock Rallies Opioid Study Success BTAI Benzinga
15 hours	What's Going On With Webull Stock Thursday? BULL -5.60% HOOD SCHW Benzinga
15 hours	Royalty Rift: Alexion Cuts Off US Royalty Payments To Xencor XNCR -12.40% AZN Benzinga
16 hours	FDA Places Partial Hold On PepGen's Myotonic Dystrophy Drug Trial PEPG -18.57% Benzinga
Mar-04	What's Going On With Anavex Life Sciences Stock On Wednesday? AVXL +6.61% Benzinga
Mar-04	KALA BIO Eyes Pharma R&D Spend With Secure AI Licensing Model KALA -20.36% KALA Benzinga
Mar-04	What's Going With SELLAS Life Sciences Stock On Wednesday? SLS Benzinga
Mar-04	Firefly Neuroscience Skyrockets - Brain Scan Breakthrough Fuels Rally AIFF +126.28% AIFF -8.39% Benzinga
Mar-04	Micro-Cap Can-Fite BioPharma Shares Surge On Successful Pancreatic Cancer Drug Study CANF +20.40% Benzinga
Mar-04	What's Going On With uniQure Stock Wednesday? QURE Benzinga
Mar-04	What's Going On With Aardvark Therapeutics Stock On Wednesday? AARD +15.10% Benzinga
Mar-04	Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars MRNA +15.99% ROIV +6.00% BNTX ABUS Benzinga
Mar-04	Klotho Neurosciences Expands Into Mining With Greenland Mines Deal KLTO -23.35% Benzinga
Mar-04	Klotho Neurosciences Expands Into Mining With Greenland Mines Deal KLTO -23.35% Benzinga
Mar-04	EXCLUSIVE: Hoth Therapeutics Integrates OpenAI API To Support Drug Development For Aggressive Cancers NVO +5.02% HOTH Benzinga
Mar-03	AI-Powered Tempus Inks New Multi-Year Merck Deal TEM MRK Benzinga
Mar-03	Core Scientific's Bitcoin Mining Revenue Slides, But CoreWeave Deal Ahead of Schedule CRWV +7.75% CORZ -7.22% CRWV -5.47% Benzinga
Mar-03	Theravance Biopharma Plummets As Phase 3 Study Falls Short TBPH -26.33% Benzinga
Mar-03	Nvidia's Genomic Analysis Suite To Help Speed Up Residual Cancer Detection COHR -6.06% NVDA Benzinga
Mar-03	What's Going On With Penny Stock OneMedNet On Tuesday? ONMD -12.54% ONMD PLTR Benzinga
Mar-03	Why Is Eye-Disease-Focused Harrow Stock Falling Today? HROW -27.96% Benzinga
Mar-03	EXCLUSIVE: Adial Pharma Eyes Europe Deal For Lead Drug For Alcohol Use Disrder Worth Up To $60 Million ADIL -7.29% Benzinga
Mar-03	Credo Technology Strong Earnings FailS To Stem Stock Slide CRDO -14.81% Benzinga
Mar-03	Tonix Pharmaceuticals Stock Dips After Nasdaq Uplisting TNXP Benzinga
Mar-03	Surgery Partners Stock Hits 52-Week Low - Here's Why SGRY -12.34% Benzinga
Mar-03	Coherent Stock Pulls Back After 15% Surge On Multibillion Nvidia AI Deal COHR -6.06% NVDA Benzinga
Mar-02	Elevance Health Stock Sinks After CMS Freezes Medicare Advantage Enrollment ELV -8.10% Benzinga
Mar-02	AbbVie Says 55% Of Crohn's Patients Reached Remission With Skyrizi, Bolsters Competitive Positioning Against Johnson & Johnson ABBV JNJ Benzinga
Mar-02	Tilray Brands Acquires BrewDog Assets - A $200 Million Revenue Boost On The Horizon TLRY Benzinga
Mar-02	Tilray Brands Acquires BrewDog Assets - A $200 Million Revenue Boost On The Horizon TLRY Benzinga
Mar-02	Weight Loss Data From Obese Mice Looks Promising For Alaunos Therapeutics, But Shares Drop TCRT Benzinga
Mar-02	Tiny Biotech Rallybio Stock Surges As $500 Million-Backed Merger Fuels Investor Optimism RLYB +45.49% Benzinga
Mar-02	United Therapeutics' Trial Shows 55% Drop in Lung Disease Worsening UTHR Benzinga
Mar-02	Intellia Therapeutics Stock Gains - FDA Lifts Clinical Hold On Pivotal Trial NTLA +12.05% Benzinga
Mar-02	Rhythm Pharmaceuticals Discloses 18.8% BMI Drop In Rare Obesity Patients RYTM Benzinga
Mar-02	uniQure Stock Plunges 40% After FDA Shocker QURE -32.82% Benzinga
Mar-02	Ascendis Wins FDA Approval For Rare Disease Therapy ASND Benzinga
Mar-02	Why Is Aardvark Therapeutics Stock Sinking Monday? AARD -56.20% Benzinga
Mar-02	BioMarin Strengthens PKU Portfolio With FDA Approval For Younger Patients BMRN FOLD Benzinga
Feb-27	What's Going On With Novavax Stock On Friday? NVAX -9.38% SNY Benzinga
Feb-27	Tiny Pain-Focused Biotech Ensysce Biosciences Surges Amid Strategic Review ENSC +57.77% Benzinga
Feb-27	Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter DNA -30.48% Benzinga
Feb-27	ANI Pharmaceuticals Turns Profit, Rare Disease Sales Surge 50% ANIP Benzinga
Feb-27	Generic Drugs Focused Amneal Pharmaceuticals Revenue Crosses $800 Million AMRX Benzinga
Feb-27	Neurogene Stock Soars On FDA Breakthrough Tag For Rett Gene Therapy NGNE +19.36% Benzinga
Feb-27	Cancer Test Maker Caris Life Sciences Unveils Breakthrough In Early Cancer Detection, Profit Surprise CAI Benzinga
Feb-27	Why Is Duolingo Stock Sinking Friday? DUOL -14.01% Benzinga
Feb-26	Boston Scientific Halts Use Of Select Stent Delivery Devices After Patient Deaths BSX Benzinga
Feb-26	Bristol Myers Says New Breast Cancer Drug Shows Survival Benefit In Pretreated Patients BMY Benzinga
Feb-26	COVID-19 Vaccine Maker Novavax Swings To Profit As Sales Climb NVAX +17.42% NVAX -9.38% Benzinga
Feb-26	Eli Lilly's New Oral Weight Loss Drug Outperforms Semaglutide, Eyes Potential US Approval In Q2 NVO LLY Benzinga
Feb-26	What's Driving Teladoc Health's Rally? TDOC +15.05% Benzinga
Feb-26	AtaiBeckley Touts Social Anxiety Breakthrough With Phase 2 Trial Data ATAI -14.06% Benzinga
Feb-26	Argenx Touts Positive Phase 3 Eye Disease Study Results ARGX -5.56% Benzinga
Feb-26	ImmunityBio Investors Rally Behind Cancer Trial Milestone IBRX Benzinga
Feb-26	IonQ Stock Gains, Europe's Quantum Leap Sparks Rally IONQ +21.70% Benzinga
Feb-26	PROCEPT BioRobotics Stock Hits 52-Week Low - Here's Why PRCT -15.12% Benzinga
Feb-26	Sarepta CEO To Jump Ship After 'Tumultuous' Year SRPT -8.01% DYN Benzinga
Feb-25	Pfizer's Braftovi Regimen Wins Complete FDA Nod For Colorectal Cancer Treatment PFE Benzinga
Feb-25	ImmunityBio Supersedes Expectations With Fivefold Revenue Increase IBRX -17.40% Benzinga
Feb-25	Ionis Guides Below 2026 Sales Views Despite Strong Growth From Lead Drug IONS -5.29% Benzinga
Feb-25	Acadia Healthcare Shares Surge 23% Following Q4 Revenue Beat, Capacity Growth ACHC +21.37% ACHC +6.96% Benzinga
Feb-25	Vanda Pharmaceuticals Breaks Through With FDA Approval, Decision Date For Skin Drug VNDA Benzinga
Feb-25	Gilead Snaps Up Arcellx For $115 Per Share - A $7.8 Billion Bet On Cancer Therapy GILD ACLX Benzinga
Feb-25	Ozempic Price War - Novo Nordisk Slashes Prices By 50% LLY NVO Benzinga
Feb-25	Charles River Labs Breaks The Mold, Announces Bold Divestiture Plans IQV CRL Benzinga
Feb-25	Gilgamesh Withdraws Patent Fight Against Enveric After $1.2 Billion AbbVie Deal, CEO Says Key Drug Claims Now Uncontested ENVB +9.09% ABBV Benzinga
Feb-25	GSK Expands Pipeline With $950 Million Pulmonary Hypertension Power Play GSK RAPT Benzinga
Feb-24	Iovance Biotherapeutics Explodes Over 20% - Early Trial Data Sparks Investor Frenzy IOVA +30.80% Benzinga
Feb-24	Henry Schein Stock Hits 52-Week High - Here's Why HSIC Benzinga
Feb-24	Tampa General Hospital Adopts Small-Cap Microbot Medical's Robotic System MBOT +23.90% Benzinga
Feb-24	Regeneron, Sanofi Blockbuster Dupixent Scores FDA Nod For Rare Sinus Condition REGN SNY Benzinga
Feb-24	What's Going On With Vanda Pharma Stock Tuesday? VNDA Benzinga
Feb-24	What's Going On With Fulcrum Therapeutics Stock Tuesday? FULC -21.21% Benzinga
Feb-24	Hims & Hers Stock Stumbles - Cautions About Pressure Due To Super Bowl Ad, Change In Shipping Cadences HIMS Benzinga
Feb-24	What's Going On With Kyntra Bio Stock Tuesday? KYNB -9.57% PFE Benzinga
Feb-24	EXCLUSIVE: Penny Stock Nexalin Advances Pivotal Trial Aiming To Tackle Severe Insomnia NXL +15.06% Benzinga
Feb-24	Protara's Experimental Bladder Cancer Drug Shows Encouraging Results TARA -26.38% Benzinga
Feb-24	Why Is MacroGenics Stock Sinking Tuesday? MGNX Benzinga
Feb-24	Vir Biotechnology Stock Hits 52-Week High Tuesday - Here's Why VIR +27.73% Benzinga
Feb-24	Novo Nordisk's China Obesity Drug Cuts Nearly One-Fifth Of Body Weight NVO LLY Benzinga
Feb-23	Viking Therapeutics Stock Gains Amid Obesity Drug Buzz NVO -16.43% VKTX +11.05% Benzinga
Feb-23	Bristol-Myers Touts Promising Data From Blood Disorder Study BMY Benzinga
Feb-23	ImmunityBio Explodes To Near 52-Week High As Bladder Cancer Drug Anktiva Drives Massive 700% Revenue Growth IBRX +17.50% IBRX +12.99% Benzinga
Feb-23	Novo Nordisk's Loss Is Eli Lilly's Gain NVO -16.43% LLY Benzinga
Feb-23	Gossamer Bio Plans FDA Talks After Narrow Miss In Key Pivotal Study, Stock Sinks GOSS -80.13% Benzinga
Feb-23	GRAIL Stock Tumbles - National Health Service Galleri Trial To Blame GRAL -14.30% Benzinga
Feb-23	Merck's Strategic Shift Signals New Growth Horizons MRK Benzinga
Feb-23	MoonLake Immunotherapeutics Data Shows Phase 2 Success For Chronic Back Pain MLTX Benzinga
Feb-23	Vanda Pharmaceuticals FDA Approval Dawns A New Era For Bipolar And Schizophrenia Treatment VNDA +41.49% Benzinga
Feb-23	FDA Accepts Teva's New Long-Acting Schizophrenia Treatment Application TEVA Benzinga
Feb-23	Gilead Buys Arcellx To Fast-Track Next-Gen Myeloma Drug ACLX +77.43% GILD Benzinga
Feb-23	Novo Nordisk Stock Hits 52-Week Low After Weight-Loss Drug Falls Short Against Eli Lilly's NVO -16.43% LLY Benzinga
Feb-20	Tandem Diabetes Shares Rise 33% On Earnings Beat, Margin Expansion, Growth Outlook TNDM +32.67% Benzinga

Vandana Singh

Recent Articles by Vandana Singh

Upgrade your FINVIZ experience